Image 1 (50436 0402 1)
Cyclobenzaprine Hydrochloride
Product Images NDC 50436-0402
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50436-0402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (50436 0402 2)
Image 3 (50436 0402 3)
This is a description for a medication called Cyclobenzaprine Hydrochloride. Each tablet contains 10 mg of Cyclobenzaprine hydrochloride. The medication is dispensed in a well-closed container with a child-resistant closure. It is recommended to keep the medication out of reach of children and store it at a controlled room temperature of 20-25 °C (68-77 °F). The manufacturer of the medication is TEVA PHARM USA, INC. The packaging contains dosage information. There is also information about the distributor, Unit Dose Services, LLC, located in Dania, L. 33004. The lot number and expiration date of the medication are also mentioned.*
Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)
Not available*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
